StandardAero, Inc. SARO 深 滬
已收盤 06-05 16:00:00 美东时间
25.61
+0.060
+0.23%
華盛通- 最 高25.75
- 今 開25.43
- 成交量 238.30万股
- 最 低 25.26
- 昨 收 25.55
- 總市值 85.15亿
- 52周最高 34.48
- 市盈率 靜 30.86
- 換手率 0.72%
- 52周最低 23.83
- 委 比 -57.89%
- 總股本 3.32亿
- 歷史最高 34.48
- 量 比 0.48
- 振 幅 1.92%
- 歷史最低 21.31
- 每 手 1
- 風險率 2.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多This Truist Securities Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Analyst rating changes: Stifel and Piper Sandler downgrade FULC, while Truist, Jefferies downgrade TMHC and SARO respectively. See more views.
06-03 21:15
美股大行评级 | 潜在涨幅43%，慧与获11家大行集体上调目标价；最高300美元，Credo获9家大行集体上调目标价
今日重点评级关注：Ascendiant Capital：维持Genasys"买入"评级，目标价从5.5美元升至6美元；Citizens：维持Abivax"跑赢大市"评级，目标价从131美元升至187美元
06-03 11:17
Jefferies Downgrades StandardAero to Hold, Lowers Price Target to $30
Jefferies analyst Sheila Kahyaoglu downgrades StandardAero (NYSE:SARO) from Buy to Hold and lowers the price target from $34 to $30.
06-02 23:19
StandardAero Appoints Paul McElhinney As CEO, Effective October 1
StandardAero (NYSE: SARO), a leading independent pure-play provider of aerospace engine aftermarket services, today announced that, after 13 years leading the Company and 45 years in the aerospace industry, Russell FordStandardAero (NYSE:SARO), a leading independent
06-02 19:12
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Shares of space-related companies are trading higher. The industry may be rallying ahead of the anticipated SpaceX IPO.
Shares of space-related companies are trading higher. The industry may be rally...
05-12 03:54
UBS Upgrades StandardAero to Buy, Lowers Price Target to $34
UBS analyst Gavin Parsons upgrades StandardAero (NYSE:SARO) from Neutral to Buy and lowers the price target from $35 to $34.
05-11 20:58
财报速睇 | StandardAero, Inc. 2026财年Q1营收16.27亿美元，同比增长13.3%；归母净利润0.80亿美元，同比增长27.0%
华盛资讯5月8日讯，StandardAero, Inc.公布2026财年Q1业绩，公司Q1营收16.27亿美元，同比增长13.3%，归母净利润0.80亿美元，同比增长27.0%。
05-08 07:20
UPDATE: StandardAero Q1 Adj. EPS $0.33 Beats $0.28 Estimate, Sales $1.627B Beat $1.485B Estimate
StandardAero (NYSE:SARO) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.28 by 17.86 percent. This is a 13.79 percent increase over earnings of $0.29 per share from the same
05-08 05:25
